Safety and Tolerability of RTX-134 in Adults With Phenylketonuria
NCT04110496
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class
Stopped
The trial was discontinued by the Sponsor
Conditions
Phenylketonurias
Interventions
DRUG:
RTX-134
Sponsor
Rubius Therapeutics